Evidence-gap map · non-drug interventions

Cystic Fibrosis evidence gaps

202 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Cystic Fibrosis, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

202registered non-drug trials
16with results posted
14recruiting as of 2026-11-16
73group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Cystic Fibrosis by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (42)2·····281 with results293533·55
Rehabilitation and therapy services (17)······7·52··3·23
Breathing and respiratory training (10)······51 with results·31····13
Mind-body and psychological approaches (19)3·13··2·441·1161
Cognitive training and education (17)1··3··1··42·2·63
Diet, fasting and nutrition (6)···1······331·1·
Neuromodulation and electrical stimulation (3)11 with results·····1····11 with results11 with results··1
Oxygen, light, temperature and manual therapies (4)···11 with results2········11 with results··
Supplements and nutraceuticals (50)··21··111 with results21 with results272 with results253 with results442122 with results
Other devices and digital tools (10)····1·2·1·21 with results···13
Other behavioural, not yet classified (36)··32 with results61 with results·1614321 with results·1·12102 with results

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Sleep and circadian approaches; Care delivery and health services.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 19 trials of mind-body and psychological approaches found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did).
  • Among the 17 trials of rehabilitation and therapy services found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did).
  • Among the 17 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did).
  • Among the 10 trials of breathing and respiratory training found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did).
  • Among the 10 trials of other devices and digital tools found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did).
  • Among the 17 trials of cognitive training and education found, none used breathing and lung function as a primary outcome (25 trials of other approaches did).
  • Among the 17 trials of rehabilitation and therapy services found, none used weight and metabolic markers as a primary outcome (20 trials of other approaches did).
  • Among the 10 trials of breathing and respiratory training found, none used weight and metabolic markers as a primary outcome (20 trials of other approaches did).
  • Among the 10 trials of other devices and digital tools found, none used quality of life as a primary outcome (18 trials of other approaches did).
  • Among the 10 trials of breathing and respiratory training found, none used symptom severity and disease activity as a primary outcome (16 trials of other approaches did).
  • Among the 10 trials of other devices and digital tools found, none used symptom severity and disease activity as a primary outcome (16 trials of other approaches did).
  • Among the 42 trials of exercise and physical activity found, none used mood, anxiety and wellbeing as a primary outcome (14 trials of other approaches did).
  • Among the 17 trials of rehabilitation and therapy services found, none used mood, anxiety and wellbeing as a primary outcome (14 trials of other approaches did).
  • Among the 10 trials of breathing and respiratory training found, none used mood, anxiety and wellbeing as a primary outcome (14 trials of other approaches did).

Questions studied but with no results posted

  • Exercise and physical activity × breathing and lung function: 9 trials registered, none with results posted
  • Rehabilitation and therapy services × physical function and exercise capacity: 7 trials registered, none with results posted
  • Mind-body and psychological approaches × feasibility, adherence and safety: 6 trials registered, none with results posted
  • Cognitive training and education × feasibility, adherence and safety: 6 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × weight and metabolic markers: 5 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × feasibility, adherence and safety: 5 trials registered, none with results posted (1 still recruiting)
  • Rehabilitation and therapy services × breathing and lung function: 5 trials registered, none with results posted
  • Mind-body and psychological approaches × breathing and lung function: 4 trials registered, none with results posted (1 still recruiting)
  • Mind-body and psychological approaches × quality of life: 4 trials registered, none with results posted
  • Cognitive training and education × quality of life: 4 trials registered, none with results posted
  • Supplements and nutraceuticals × symptom severity and disease activity: 4 trials registered, none with results posted
  • Supplements and nutraceuticals × clinical events, survival and healthcare use: 4 trials registered, none with results posted
  • Exercise and physical activity × quality of life: 3 trials registered, none with results posted
  • Exercise and physical activity × inflammation and other biomarkers: 3 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Cystic Fibrosis

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 40 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.